Explore Roche Diagnostic Point of Care testing devices, platforms, digital products, and services to bring accurate and reliable diagnostics closer to patients.
Point-of-care testing in the United Kingdom is currently at the embryo stage of development, and is approximately 10 years behind the United States in incorporation and application into clinical practice. Safeguards to ensure proper use are not in place within the UK at present, and there is ...
To determine if use of point of care testing (POCT) is less costly than laboratory testing to the National Health Service (NHS) in delivering the NHS Health Check (NHSHC) programme in the primary care setting. Observational study and theoretical mathematical model with microcosting approach. We...
The aim of this study was to quantify the impact introducing point-of-care... WYH Calderdaleandhuddersfieldnhsfoundationtrust - 《Point of Care》 被引量: 0发表: 2015年 Point of Care Testing In the last decade or so, some countries, including the United Kingdom, have seen a movement ...
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after researchers at the University of Cambridge showed that this approach was superior to virus detection alone for diagn
Recent years have shown that the diagnosis and monitoring of biomarkers involved in inflammatory-associated medical conditions such as cancer, neurological
A chemically patterned microfluidic paper-based analytical device (C-µPAD) is developed to create fluidic networks by forming hydrophobic barriers using chemical vapor deposition (CVD) of trichlorosilane (TCS) on a chromatography paper. By controlling temperature, pattern size, and CVD duration, opti...
NICE has developed a medtech innovation briefing (MIB) on i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department. The i STAT is a handheld analyser used with a range of single-use cartridges for testing blood at the point of care, such as in the emerg...
Clinical Biochemistry Department, Bedford Hospital NHS Trust, Kempston Road, Bedford.doi:10.1309/LMZ100VWSHJZPLV0J. C. MatthewsW.S. WassifBr J Biomed SciBritish journal of biomedical scienceMatthews J C, Wassif W S. Potential risk of patient misclassification using a point-of-care testing kit ...
Testing by NAAT and POC antibody testing by (A) COVIDIX Healthcare IgM/IgG kit (n = 45) and (B) SureScreen IgM/IgG kit (n = 43). Those with positive NAAT and sequence available were predominantly infected with strains containing the D614G mutation in Spike, downstream of the receptor...